NCT03850379View on ClinicalTrials.gov

Ciprofloxacin Versus Levofloxacin in Stem Cell Transplant

PHASE2CompletedINTERVENTIONAL
Enrollment

308

Participants

Timeline

Start Date

March 14, 2018

Primary Completion Date

August 30, 2024

Study Completion Date

August 30, 2024

Conditions
ProphylaxisStem Cell Transplant Complications
Interventions
DRUG

Levofloxacin

This is a prospective study comparing consecutive patients who will be be receiving ciprofloxacin prophylaxis vs. levofloxacin prophylaxis for Stem cell transplant till engraftment defined as ANC \>1000

DRUG

Ciprofloxacin

This is a prospective study comparing consecutive patients who will be be receiving ciprofloxacin prophylaxis vs. levofloxacin prophylaxis for Stem cell transplant till engraftment defined as ANC \>1000

Trial Locations (1)

48202

Henry Ford, Detroit

All Listed Sponsors
lead

Henry Ford Health System

OTHER

NCT03850379 - Ciprofloxacin Versus Levofloxacin in Stem Cell Transplant | Biotech Hunter | Biotech Hunter